ATE370962T1 - Entfernung von prionen durch den gebrauch von metalloxid partikeln - Google Patents

Entfernung von prionen durch den gebrauch von metalloxid partikeln

Info

Publication number
ATE370962T1
ATE370962T1 AT04783316T AT04783316T ATE370962T1 AT E370962 T1 ATE370962 T1 AT E370962T1 AT 04783316 T AT04783316 T AT 04783316T AT 04783316 T AT04783316 T AT 04783316T AT E370962 T1 ATE370962 T1 AT E370962T1
Authority
AT
Austria
Prior art keywords
metal oxide
biological material
prions
removal
oxide particles
Prior art date
Application number
AT04783316T
Other languages
English (en)
Inventor
Christopher Stenland
Jarrett Terry
Jeffrey Yuziuk
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Application granted granted Critical
Publication of ATE370962T1 publication Critical patent/ATE370962T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicon Compounds (AREA)
AT04783316T 2003-09-10 2004-09-07 Entfernung von prionen durch den gebrauch von metalloxid partikeln ATE370962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/659,789 US20050054003A1 (en) 2003-09-10 2003-09-10 Prion clearance using particulate metal oxides

Publications (1)

Publication Number Publication Date
ATE370962T1 true ATE370962T1 (de) 2007-09-15

Family

ID=34227009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04783316T ATE370962T1 (de) 2003-09-10 2004-09-07 Entfernung von prionen durch den gebrauch von metalloxid partikeln

Country Status (13)

Country Link
US (1) US20050054003A1 (de)
EP (1) EP1664087B1 (de)
JP (1) JP2007527405A (de)
AT (1) ATE370962T1 (de)
AU (1) AU2004272591A1 (de)
CA (1) CA2538288A1 (de)
CY (1) CY1107791T1 (de)
DE (1) DE602004008488T2 (de)
DK (1) DK1664087T3 (de)
ES (1) ES2291947T3 (de)
PL (1) PL1664087T3 (de)
PT (1) PT1664087E (de)
WO (1) WO2005026197A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4769925B2 (ja) * 2006-03-15 2011-09-07 国立大学法人東北大学 異常型プリオン蛋白質の濃縮方法、および除去方法
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
WO2017195781A1 (ja) * 2016-05-09 2017-11-16 株式会社理研テクノシステム 異常型プリオンタンパク質の感染力低減方法及びプリオン病の予防治療用医薬組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
IL89123A (en) * 1989-01-31 1993-08-18 Ilana Tamir Method for determination of ldl-cholesterol
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5290703A (en) * 1992-12-14 1994-03-01 Miles, Inc. Method for the separation of high density lipoprotein from blood samples
WO1997045746A2 (en) * 1996-05-29 1997-12-04 Mcgill University Prion protein binding proteins and uses thereof
US5808011A (en) * 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
WO2001000235A1 (en) * 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
CA2435255A1 (en) * 2001-01-16 2002-08-15 Biotransplant, Inc. Use of high density microparticles for removal of pathogens
WO2002090379A1 (en) * 2001-05-08 2002-11-14 Serologicals Royalty Company Process for inactivating prions in lipoproteins
DE60211339D1 (de) * 2001-06-22 2006-06-14 Argonide Corp Submikron filter
SG187269A1 (en) * 2003-04-04 2013-02-28 Univ North Carolina State Prion protein binding materials and methods of use

Also Published As

Publication number Publication date
JP2007527405A (ja) 2007-09-27
DK1664087T3 (da) 2007-12-27
DE602004008488D1 (de) 2007-10-04
CY1107791T1 (el) 2013-06-19
WO2005026197A1 (en) 2005-03-24
PL1664087T3 (pl) 2008-06-30
PT1664087E (pt) 2007-11-09
AU2004272591A1 (en) 2005-03-24
CA2538288A1 (en) 2005-03-24
DE602004008488T2 (de) 2008-01-03
EP1664087B1 (de) 2007-08-22
EP1664087A1 (de) 2006-06-07
ES2291947T3 (es) 2008-03-01
US20050054003A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
DK1748701T3 (da) Fremgangsmåder og sammensætninger involverende valleproteinisolater
NO20055741L (no) Nye kjemiske forbindelser
ATE445386T1 (de) Polymerische parfümpartikel
ATE496892T1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
ATE442869T1 (de) Suspension zur verminderung von geruch
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE60132978D1 (de) Hybride expression von neisseria proteinen
DE502005004912D1 (de) Reinigung von ionischen flüssigkeiten
DE59410380D1 (de) Endosomolytisch wirksame partikel
GB0216001D0 (en) Process and composition
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
DE50208268D1 (de) Verfahren zur direkten kühlung von feinteiligen feststoffen
ATE267770T1 (de) Reaktor zur herstellung von hochreinem, granularem silizium
DE10193689D2 (de) Retardpartikeldispersion
DE69917465D1 (de) Zahnpasta auf basis von feinteiligem und grossteiligem kalziumcarbonat
ATE370962T1 (de) Entfernung von prionen durch den gebrauch von metalloxid partikeln
DE60330921D1 (de) Verfahren zur Herstellung von modifiziertem Zinnoxidsol und Zinnoxid-Zirkonoxid-Mischsol.
EP1534404A4 (de) Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration
CY1109206T1 (el) gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ
AU2003251729A8 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
EA200600693A1 (ru) Пакующие клетки для рекомбинантных аденовирусов
DE60332076D1 (de) Doppelmessverfahren zur Anzeige des Inhalts von Poststücken
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ATE505538T1 (de) Dna-vektoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1664087

Country of ref document: EP